Prestige Biologics Co (XKRX:334970) FCF Margin % : -1,172.35% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Prestige Biologics Co FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Prestige Biologics Co's Free Cash Flow for the three months ended in Mar. 2024 was ₩-7,489 Mil. Prestige Biologics Co's Revenue for the three months ended in Mar. 2024 was ₩639 Mil. Therefore, Prestige Biologics Co's FCF Margin % for the quarter that ended in Mar. 2024 was -1,172.35%.

As of today, Prestige Biologics Co's current FCF Yield % is -4.14%.

The historical rank and industry rank for Prestige Biologics Co's FCF Margin % or its related term are showing as below:

XKRX:334970' s FCF Margin % Range Over the Past 10 Years
Min: -763934.51 Med: -11218.44 Max: -459.01
Current: -459.01

During the past 7 years, the highest FCF Margin % of Prestige Biologics Co was -459.01%. The lowest was -763934.51%. And the median was -11218.44%.

XKRX:334970's FCF Margin % is ranked worse than
66.03% of 1039 companies
in the Biotechnology industry
Industry Median: -139.09 vs XKRX:334970: -459.01

Prestige Biologics Co FCF Margin % Historical Data

The historical data trend for Prestige Biologics Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prestige Biologics Co FCF Margin % Chart

Prestige Biologics Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

FCF Margin %

Get a 7-Day Free Trial

-11,218.44

-3,835.36

-763,934.51

Prestige Biologics Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															-845,101.45	-15,099.52	-134.31	-247.54	-1,172.35

Competitive Comparison of Prestige Biologics Co's FCF Margin %

For the Biotechnology subindustry, Prestige Biologics Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Prestige Biologics Co's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Prestige Biologics Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Prestige Biologics Co's FCF Margin % falls into.

Prestige Biologics Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Prestige Biologics Co's FCF Margin for the fiscal year that ended in Dec. 2022 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2022 )	/	Revenue (A: Dec. 2022 )
	=	-118914.046	/	15.566
	=	-763,934.51 %

Prestige Biologics Co's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-7489.3	/	638.829
	=	-1,172.35 %

Prestige Biologics Co FCF Margin % Related Terms

Thank you for viewing the detailed overview of Prestige Biologics Co's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Prestige Biologics Co (XKRX:334970) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Prestige Biologics Co Ltd (XKRX:334970) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

197, Osongsaengmyeong 1-ro, Osong-eup, Heungdeok-gu, Chungcheongbuk-do, Cheongju-si, KOR, 28161

Website

https://www.prestigebiologics.com

Prestige Biologics Co Ltd is a CDMO-dedicated company that provides solutions of development and manufacturing tasks throughout the stages from the research/development, engineering, clinical production, commercial production, clinical support, and IND & BLA filing of biopharmaceutical products. Its product candidate includes HD201 (Herceptin Biosimilar).

Prestige Biologics Co (XKRX:334970) Headlines

No Headlines